BUDZ · Weed, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | - | $0 | $0 | $0 | - | $0 | $0 | $0 | - |
| Cost of Revenue | $0 | - | - | - | $0 | - | - | - | $0 | - |
| Gross Profit | $0 | - | - | - | $0 | - | - | - | $0 | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $67.8K | - | $58.5K | $64.1K | $383.3K | - | $64.8K | $85.3K | $136.6K | - |
| Total Operating Expenses | $164.0K | - | $66.9K | $94.0K | $434.7K | - | $92.6K | $145.0K | $170.1K | - |
| D&A | $5.6K | - | $8.2K | $5.6K | $5.7K | - | $5.6K | $8.2K | $5.7K | - |
| Operating Income | ($164.0K) | - | ($66.9K) | ($94.0K) | ($434.7K) | - | ($92.6K) | ($145.0K) | ($170.1K) | - |
| Interest Expense | - | - | - | - | $3.2K | - | $3.2K | $599 | $599 | - |
| Income Tax | $0 | - | $0 | $0 | $0 | - | - | $0 | $0 | - |
| Net Income | ($175.3K) | - | ($73.9K) | ($107.6K) | ($133.2K) | - | ($95.9K) | ($395.3K) | ($170.7K) | - |
| EPS - Basic | - | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | ($0.00) | - | ($0.00) | ($0.00) | ($0.00) | - | - | - | - | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.8K | $33.1K | $400 | $5.3K | $3.1K | $159.4K | $5.3K | $32.5K | $102.7K | $290.4K |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $182.9K | $179.9K | $192.0K | $190.6K | $170.2K | $167.6K | $200.2K | $176.8K | $188.8K | $183.6K |
| Current Assets | $12.4K | $47.7K | $10.9K | $18.5K | $35.7K | $189.9K | $39.4K | $36.9K | $128.6K | $319.9K |
| Total Assets | $515.7K | $559.9K | $532.3K | $548.9K | $575.1K | $738.4K | $596.8K | $603.3K | $703.8K | $904.1K |
| Current Liabilities | $1.35M | $1.25M | $1.05M | $996.8K | $921.4K | $959.4K | $685.0K | $595.8K | $596.3K | $648.8K |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $1.35M | $1.25M | $1.05M | $996.8K | $921.4K | $959.4K | $685.0K | $595.8K | $596.3K | $648.8K |
| Stockholders' Equity | ($837.5K) | ($688.4K) | ($519.1K) | ($447.9K) | ($346.2K) | ($221.0K) | ($88.2K) | $7.5K | $107.5K | $255.3K |
| Retained Earnings | ($86.45M) | ($86.28M) | ($85.53M) | ($85.45M) | ($85.34M) | ($84.90M) | ($84.77M) | ($84.67M) | ($84.56M) | ($84.39M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($57.7K) | - | - | - | ($71.8K) | - | - | - | ($177.7K) | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | $0 | - |
| Financing Cash Flow | $29.2K | - | - | - | ($84.3K) | - | - | - | ($10.0K) | - |
| CapEx | - | - | - | - | - | - | - | - | $0 | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | ($177.7K) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | 1.04 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -34.0% | - | -13.9% | -19.6% | -23.2% | - | -16.1% | -65.5% | -24.2% | - |
| Return on equity | 20.9% | - | 14.2% | 24.0% | 38.5% | - | 108.7% | -5259.4% | -158.8% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.01 | 0.04 | 0.01 | 0.02 | 0.04 | 0.20 | 0.06 | 0.06 | 0.22 | 0.49 |
| Quick ratio | 0.01 | 0.04 | 0.01 | 0.02 | 0.04 | 0.20 | 0.06 | 0.06 | 0.22 | 0.49 |
| Cash ratio | 0.00 | 0.03 | 0.00 | 0.01 | 0.00 | 0.17 | 0.01 | 0.05 | 0.17 | 0.45 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | -137.4x | - | -28.6x | -242.0x | -283.9x | - |
| Equity multiplier | -0.62 | -0.81 | -1.03 | -1.23 | -1.66 | -3.34 | -6.76 | 80.26 | 6.55 | 3.54 |
| Liabilities / Assets | 2.62 | 2.23 | 1.98 | 1.82 | 1.60 | 1.30 | 1.15 | 0.99 | 0.85 | 0.72 |
| Efficiency | ||||||||||
| Asset turnover | 0.00 | - | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 62.3% | - | 27.8% | 35.1% | -155.6% | - | 61.2% | 7.2% | 7.5% | - |
| Net income growth (YoY) | -31.5% | - | 22.9% | 72.8% | 21.9% | - | - | -127.9% | 13.4% | - |
| EPS growth (YoY) | 28.6% | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | 5.0% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -141.9% | -211.5% | -488.3% | - | - | - | - | - | 9573.6% | 50.4% |
Peer comparison
Same SIC group: Services-Commercial Physical & Biological Research
Comparing WEED against the 5 most active filers in the same SIC group.